Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers
Crossref DOI link: https://doi.org/10.1038/s41401-021-00710-8
Published Online: 2021-07-15
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Lu
Li, Wei
Yang, Le
Guo, Zi-tao
Xue, Hao
Xie, Ning-jie
Chen, Xiao-yan
Text and Data Mining valid from 2021-07-15
Version of Record valid from 2021-07-15
Article History
Received: 4 February 2021
Accepted: 30 May 2021
First Online: 15 July 2021
Competing interests
: The authors declare no competing interests.